Detalhe da pesquisa
1.
Impact of endothelial shear stress on absorption process of resorbable magnesium scaffold: A BIOSOLVE-II substudy
Cardiovasc. revasc. med;
29: 9-15, Aug. 2021. graf, ilus, tab
Artigo
em Inglês
| CONASS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1293172
2.
Safety and Clinical performance of the drug-eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries at 36- month follow-up: BIOSOLVE-II and BIOSOLVE-III
J. Am. Coll. Cardiol;
74(13 supl): 187-187, Oct., 2019.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1024965
3.
Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: an optical coherence tomography analysis
Eur Heart J Cardiovasc Imaging;
20(8): 916-924, Ago. 2019. tabela, gráfico, ilustração
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1024905
4.
Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12 months: Pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials
Int. j. cardiol;
300(1): 60-65, Jul, 2019. tabela, gráfico
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1103433
5.
First report of edge vascular response at 12 months of Magmaris, a second-generation drug-eluting resorbable magnesium scaffold, assessed by grayscale intravascular ultrasound, virtual histology, and optical coherence tomography. A biosolve-II trial sub-study
Cardiovasc Revasc Med;
20(5): 392-398, May 2019. ilus, tab
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1006900
6.
Serial 3 dimensional optical coherence tomography assessment of jailed side branch by second-generation drug-eluting absorbable metal scaffold (from the BIOSOLVE-II Trial)
Am. j. cardiol;
123(7): 1044-1051, Apr. 2019. tab, ilus, graf
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1022205
7.
Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III
Catheter. cardiovasc. interv;
92(7): 502, : 511, Dec. 2018. graf, tab, ilus
Artigo
em Inglês
| SES-SP, CONASS, SESSP-IDPCPROD, SES-SP | ID: biblio-1247595
8.
In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial
Int J Cardiol;
255(mar): 22-28, 2018. tab, graf, ilus
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1063465
9.
Duration of dual antiplatelet therapy following drug-eluting stent implantation in diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials
Prog Cardiovasc Dis;
60(4-5): 500-507, 2018. graf, tab
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1065739
10.
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
EuroIntervention;
13(4): 432-439, 2017.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1062707
11.
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Eur. heart j;
37(35): 2701-2709, 2016.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1062639
12.
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
Lancet;
387(10013): 31-39, 2015.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1064583
13.
Bioresorbable scaffolds: rationale, current status,challenges, and future
Eur. heart j;
35: 765-776, 2014. ilus
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1062635
14.
Regurgitação aórtica após substituição valvular aórtica transcateter: decepção ou tempestade em copo d'agua? / Aortic regurgitation after transcatheter aortic valve replacement: disappointment or storm glass of water?
Rev. bras. cardiol. invasiva;
21(2): 97-99, abr.-jun. 2013.
Artigo
em Português
| LILACS | ID: lil-681939
15.
Valvuloplastía aórtica con balón como puente para reemplazo valvular aórtico percutáneo o quirúrgico en el manejo de la estenosis aórtica severa / Percutaneous aortic balloon valvuloplasty as a bridge to aortic valve replacement in severe aortic stenosis
Rev. chil. cardiol;
31(1): 11-17, 2012. ilus, tab
Artigo
em Espanhol
| LILACS | ID: lil-643181
16.
Radiación gamma intracoronaria después de angioplastia con balón: la experiencia venezolana / Intracoronary gamma radiation after angioplasty with baloom: the venezuelan experience
Gac. méd. Caracas;
110(3): 361-371, jul.-sept. 2002. ilus, tab
Artigo
em Espanhol
| LILACS | ID: lil-401997
17.
Treatment of focal in-stent restenosis with balloon angioplasty alone vs. stenting: short- and long-term results
American Heart Journal;
141(4): 610-614, 2001.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1059608
18.
Treatment of in-stent restenosis with excrimer laser coronary angioplasty versus rotational atherectomy
Circulation;
101(21): 2484-2489, May 30 2000. ilus
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1061971